PRLD — Prelude Therapeutics Incorporated News Story

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Market Cap
$236.22m
Enterprise Value
$84.47m
Revenue
$12.14m

Quality
Value
Momentum
StockRank™

All News

Brief: Prelude Therapeutics Inc Files For Mixed Shelf Of Up To $400 Million – SEC Filing

Prelude Therapeutics Incorporated

30/05/2024 22:29

Prelude Therapeutics Inc  PRLD.O :
    * PRELUDE THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO
$400
MILLION – SEC FILING

Source text for Eikon:  ID:n0001193125-24-150375 
Further company coverage:  PRLD.O

PRLD — Prelude Therapeutics Incorporated News Story

Brief: Prelude Therapeutics Inc Files For Mixed Shelf Of Up To $400 Million – SEC Filing

Recent news on Prelude Therapeutics Incorporated

Brief: Prelude Announces Clinical Trial Collaboration And Supply Agreement With Lilly To Evaluate KAT6A Selective Degrader PRT13722 In Combination With Verzenio® And Inluriyo® In Patients With HR+/HER2- Breast Cancer

U.S. RESEARCH ROUNDUP-Celcuity, Fluence Energy, Salesforce

Prelude Therapeutics Incorporated reports results for the quarter ended June 30 - Earnings Summary

Prelude Therapeutics Q2 revenue beats analyst expectations, net loss narrows

Prelude Therapeutics Incorporated expected to post a loss of 20 cents a share - Earnings Preview